[Metabolism of mitomycin C by human liver microsomes in vitro]. 2007

Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
Department of Radiotherapy, Weifang People' s Hospital, Weifang 261000, China.

To provide the profiles of metabolism of mitomycin C (MMC) by human liver microsomes in vitro, MMC was incubated with human liver microsomes, then the supernatant component was isolated and detected by HPLC. Types of metabolic enzymes were estimated by the effect of NADPH or dicumarol (DIC) on metabolism of MMC. Standard, reaction, background control (microsomes was inactivated), negative control (no NADPH), and inhibitor group (adding DIC) were assigned, the results were analyzed by Graphpad Prism 4. 0 software. Reaction group compared with background control and negative control groups, 3 NADPH-dependent absorption peaks were additionally isolated by HPLC after MMC were incubated with human liver microsomes. Their retention times were 10. 0, 14. 0, 14. 8 min ( named as Ml, M2, M3) , respectively. Their formation was kept as Sigmoidal dose-response and their Km were 0. 52 (95% CI, 0. 40 - 0.67) mmol x L(-1), 0. 81 (95% CI, 0. 59 - 1. 10) mmol x L(-1), 0. 54 (95% CI, 0. 41 -0. 71) mmol x L(-1) , respectively. The data indicated that the three absorption peaks isolated by HPLC were metabolites of MMC. DIC can inhibit formation of M2, it' s dose-effect fitted to Sigmoidal curve and it' s IC50 was 59. 68 (95% CI, 40. 66 - 87. 61) micromol x L(-1) , which indicated DT-diaphorase could take part in the formation of M2. MMC can be metabolized by human liver microsomes in vitro, and at least three metabolites of MMC could be isolated by HPLC in the experiment, further study showed DT-diaphorase participated in the formation of M2.

UI MeSH Term Description Entries
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D001728 Dicumarol An oral anticoagulant that interferes with the metabolism of vitamin K. It is also used in biochemical experiments as an inhibitor of reductases. Bishydroxycoumarin,Dicoumarin,Dicoumarol
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D016685 Mitomycin An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis. Mitomycin C,Ametycine,Mitocin-C,Mitomycin-C,Mutamycin,NSC-26980,Mitocin C,MitocinC,NSC 26980,NSC26980

Related Publications

Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
May 2017, Planta medica,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
February 2008, Drug metabolism and disposition: the biological fate of chemicals,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
April 2014, Journal of agricultural and food chemistry,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
August 1981, Biochemistry,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
May 1962, The Journal of pharmacology and experimental therapeutics,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
January 1975, Naunyn-Schmiedeberg's archives of pharmacology,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
June 1982, Biochemical pharmacology,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
December 2007, Drug metabolism letters,
Fu-rong Hao, and Min-fen Yan, and Zhuo-han Hu, and Yi-zun Jin
August 2019, Xenobiotica; the fate of foreign compounds in biological systems,
Copied contents to your clipboard!